Olink

Olink®
Part of Thermo Fisher Scientific

Circulating HLA-G and its association with cardiovascular markers in pregnancy

Journal of Reproductive Immunology, 2021

Lekva T., Jacobsen D., Sugulle M., Moe K., Fjeldstad H., Dechend R., Staff A.

Disease areaApplication areaSample typeProducts
Immunological & Inflammatory Diseases
Obstetrics
Pathophysiology
Plasma
Olink Target 96

Olink Target 96

Abstract

Human Leukocyte Antigen-G (HLA-G) prevents the activity of immune cells and is decreased in women with preeclampsia. We aimed to investigate the associations between circulating soluble HLA-G (sHLA-G) and 92 cardiovascular disease-related biomarkers from a previously published multiplex study in women with preeclampsia and controls. We found 15 markers significantly associated with circulating sHLA-G in univariate analyses. After multivariable adjusted regression, only proto-oncogene tyrosine-protein kinase Src (SRC) and vascular endothelial growth factor D were significantly associated with sHLA-G. Low SRC, previously observed in the circulation of preeclamptic women, may be regulated by low sHLA-G, and reflect decreased trophoblast differentiation and syncytical formation.

Read publication ↗